ArticleMaterials today. Bio2026
Injectable alginate hydrogels improve the effects of subretinal hiPSC-derived RPE cell therapy on retinal degeneration in rats.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subretinal delivery of retinal pigment epithelium (RPE) cells is an important treatment for retinal degeneration patients, and the cell suspension method is the most common approach. Injectable hydrogel-mediated cell engraftment is expected to potentially improve cell transplantation outcomes. Here, alginate hydrogels were used to deliver human-induced pluripotent stem cell (hiPSC)-differentiated RPE cells or an RPE cell line (ARPE-19 cells) into the subretinal sites of Royal College of Surgeons (RCS) rats with retinal degeneration. RPE cell-grafted sites were monitored operating a retinal imaging instrument, and the visual functions of RCS rats were assessed via optomotor response (OMR) and electroretinogram (ERG), and retinal structure was analyzed histologically. The OMR results revealed similar spatial vision recovery among the cell transplantation groups injected with and without hydrogels. However, the ERG results revealed superior light perception in RCS rats treated with hydrogel-mediated RPE cell transplantation, particularly compared to hiPSC-derived RPE cell transplantation. This is because OMR evaluates movement of RCS rat eyes, which is difficult to evaluate visual acuity precisely. Optical coherence tomography at four and eight weeks post-transplantation confirmed long-term RPE cell retention and a thickened outer nuclear layer at injection sites after RPE cell engraftment with injectable hydrogels but not without injectable hydrogels; this was supported by the histological results showing retinal outer nuclear layer preservation for 8 weeks. These findings indicate that compared with RPE cell suspensions, alginate hydrogels enhance RPE cell transplantation outcomes and that the structural and functional rescue effects of hiPSC-derived RPE cells with injectable hydrogels are valuable. Hydrogel-mediated delivery represents a promising strategy for improving subretinal cell transplantation efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.